Understanding & satisfying payer & stakeholder needs to demonstrate cost-effectiveness & product value Conference dates: 18th-19th March, 2010 Venue: Budapest, Hungary Event Overview Increasing national healthcare budgetary pressures, are forcing manufacturers to think out of the box and implement more innovative reimbursement models and value-based schemes. Demonstrating product value with data that really counts in payers’, regulators’ and other stakeholders’ decision-making processes, is essential in order to gain and retain access in key markets…

More: 
Innovative Market Access Strategies For Medical Devices And Technologies Conference, March, 2010

You may also like:

• NICE’s Original Guidance On Preventing Fractures Due To Osteoporosis Still Stands Following Challenge
• Slowing Of Downward Trend In Smoking Shows Need For Strong Comprehensive Tobacco Strategy
• UCB Accelerates Transition To Become Patient-centric Global Biopharmaceutical Leader With Decision To Exit The Primary Care Market In The U.S.
• The Endocrine Society Recommends Against Changes In Blood Sugar Control Goals In Response To Study On A1C Levels And Mortality Published In Lancet
• Pathway Genomics Conversation Starter #3: After Genetic Testing, What Then?
• Rosetta Genomics Fortifies Patent Position With U.S. Allowance Of Claims Covering Human MicroRNAs MiR-21 And Hcmv-miR-UL112
• Pharmacy Expedition To Challenge Perceptions, Australia
• Boston Scientific To Participate In Morgan Stanley Global Healthcare Conference
• New Edition Of Guidelines For Involving Communities In HIV Prevention Research Released At International AIDS Conference
• Cardinal Health Introduces New Features To Tool That Has Recovered Nearly $20 Million In Prescription Reimbursements For Retail Pharmacies